Haghikia · Immunity 2015 · Preclinical animal and cellular mechanistic study · n=?

Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine.

Cited 936 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Preclinical animal (experimental autoimmune encephalomyelitis) and in vitro mechanistic study.

PubMed 26488817 · doi:10.1016/j.immuni.2015.09.007 · record verified 2026-08-30

What was done

Researchers investigated how dietary fatty acids influence intestinal and central nervous system T-cell responses using in vitro cell culture and the experimental autoimmune encephalomyelitis (EAE) mouse model of multiple sclerosis. They evaluated the effects of long-chain fatty acids (LCFAs) and short-chain fatty acids (SCFAs) on T-cell differentiation (Th1, Th17, and regulatory T cells), intracellular signaling pathways (p38-MAPK, JNK1), gut metabolite composition, and EAE disease severity/axonal damage.

What was found

The abstract reports no numerical data or effect sizes. Directionally, LCFAs promoted the differentiation and proliferation of Th1 and Th17 cells, impaired their intestinal sequestration via the p38-MAPK pathway, reduced gut SCFAs, and exacerbated EAE severity. In contrast, SCFAs expanded gut regulatory T (Treg) cells by suppressing JNK1 and p38 signaling, and SCFA treatment ameliorated EAE disease severity and reduced axonal damage.

Why it matters

This study defines a specific gut-to-brain mechanism through which dietary fatty acids alter intestinal T-cell populations to either aggravate or suppress central nervous system autoimmunity, pointing to dietary short-chain fatty acids as a potential therapeutic target in multiple sclerosis.

Limits

The study is preclinical, relying on animal models (EAE) and cell culture; findings cannot be assumed to translate directly to human multiple sclerosis. The abstract provides no sample sizes, dietary dosages, quantitative metrics, or statistical significance estimates.

Cited by